【24h】

Genetic testing for podocyte genes in sporadic focal segmental glomerulosclerosis.

机译:散核局灶性节段肾硬化卟啉粥样硬化细胞基因的遗传检测。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Donation after cardiac death (DCD) liver transplantation is increasingly common but concerns exist over the development of biliary complications and ischemic cholangiopathy (IC). This study aimed to compare outcomes between DCD and donation after brain death (DBD) liver grafts. Studies reporting on post-transplantation outcomes after Maastricht category III DCD liver transplantation were screened for inclusion. Odds ratios (OR) with 95% confidence intervals were produced using random-effects models for the incidence of biliary complications, IC, graft and recipient survival. Meta-regression was undertaken to identify between-study predictors of effect size for biliary complications and IC. PROSPERO Record: CRD42012002113. Twenty-five studies with 62?184 liver transplant recipients (DCD?=?2478 and DBD?=?59?706) were included. In comparison with DBD, there was a significant increase in biliary complications [OR?=?2.4 (1.9, 3.1); P?
机译:心脏死亡后捐赠(DCD)肝移植越来越普遍,但对胆道并发症的发育和缺血性胆管病(IC)存在担忧。本研究旨在比较脑死亡(DBD)肝移植后DCD和捐赠之间的结果。筛选筛选Maastricht III类DCD肝移植后移植后结果的研究。利用随机效应模型为胆道并发症,IC,移植物和受体存活率的发生率产生了95%置信区间的差距比率(或)。荟萃回归是为了确定胆道并发症和IC的效果大小的研究预测因子。 Prospero Record:CRD42012002113。包括62次肝移植受者的二十五项研究(DCD?=?2478和DBD?59?706)。与DBD相比,胆汁并发症的显着增加[或?=?2.4(1.9,3.1); p?<?0.00001]和IC [或?=?10.5(5.7,19​​.5); P?<α00001]后DCD肝移植后。与DBD相比,在1年[或吗?= 0.7(0.5,0.8); p?=?0.0002]和3?年[或?=?0.6(0.5,0.8); P?= 0.001],DCD肝移植后移植物存活率显着降低。在1?一年中,还有一个不显着的减少[或?=?0.8(0.6,1.0); p?=?0.08]和3年的显着降低[或?=Δ0.7(0.5,1.0); p?=Δ04]在DCD肝移植后受到受体存活。进入Meta回归模型的11个因素,但没有解释研究之间的效果规模的变化。 DCD肝移植与胆汁并发症,IC,移植物损失和死亡率增加有关。中心之间的效果大小的显着原因差异存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号